US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Ind…
The need to be thinner has fuelled the sale of weight-loss drugs such as Ozempic and Wegovy across the globe. In Hollywood, it has become the biggest open secret. It has also racked up billions of …
As obesity continues to affect over a billion people globally, experts are calling for a shift in how the condition is defined and diagnosed.
Relying solely on Body Mass Index (BMI) is increasingly…
Good news awaits millions of Americans suffering from obesity and desperate to shed the kilos. The Biden administration has announced a proposal to require Medicare and Medicaid to cover weight-loss…
Ozempic, a drug originally developed to manage Type 2 diabetes, has garnered widespread attention for its impressive weight loss benefits. However recent research suggests that this so-called…
The world has long been concerned about obesity.
It has long been known for its connections to non-communicable diseases like diabetes, cardiovascular disease, and hypertension.
Initially presented as…